Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebif CNS Effects in RRMS
NCT01085318Phase 4Completed
- Sponsor
- EMD Serono
- Start
- Jun 2010
- Primary completion
- Feb 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon beta in relapsing-remitting multiple sclerosis (RRMS), sponsored by EMD Serono. Started Jun 2010; status: completed.
02
Drugs
interferon beta
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01085318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01085318.